Rheumatology Advance Access originally published online on October 17, 2007
Rheumatology 2007 46(12):1859; doi:10.1093/rheumatology/kem267
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTERS TO THE EDITOR |
Adherence to immunosuppressant drugs in patients with connective tissue diseases
Barts and The Royal London NHS Trust—Rheumatology, Bancroft Road, Stepney Green, London E1 4DG, UK
Correspondence to: D. Pyne, Barts and The Royal London NHS Trust—Rheumatology, Bancroft Road, Stepney Green, London E1 4DG, UK. E-mail: dev.pyne@bartsandthelondon.nhs.uk
| The first 10% of the full text of this article appears below. |
SIR, We read with interest the Editorial by Chambers et al. [1] regarding treatment adherence in systemic lupus erythematosus (SLE). It has been estimated that up to 50% of patients who suffer from chronic diseases do not adhere to